InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Wurth Douglas Clark, Chairman & CEO. Director active across 2 companies, notably Good Works II Acquisition Corp.. Aggregated, 4 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €102k. History available since 11 November 2021. The latest transaction was filed on 17 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
40,000 shares@ US$1.1782.39% mcap41.8% of flowCommon StockSEC:0001213900-22-013510:0
Ideal exit: 12 Dec 2022 (T+270)
60,000 shares@ US$1.093.33% mcap58.2% of flowCommon StockSEC:0001213900-22-013129:0
Ideal exit: 11 Dec 2022 (T+270)
250,000 shares0Common StockSEC:0001213900-21-059613:0
250,000 shares0Common StockSEC:0001213900-21-059613
4 of 4 declarations
About Wurth Douglas Clark
Douglas Clark Wurth is the Chief Executive Officer of Good Works II Acquisition Corp. and Bluejay Diagnostics, Inc. He oversees the operations and strategy of both companies, which focus on innovation in the healthcare sector. His leadership is essential for the growth and development of these companies.
